BioSpace News Archive

Job Trends

Every Child Pediatrics brings whole health/whole family care to Lakewood

Complete healthcare and support services to children, regardless of family income

June 5, 2018
·
1 min read
Pharm Country

Ferring to Present Clinical Data on Efficacy and Safety of CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep at Digestive Disease Week

Tuesday, June 5, 12:00-2:00 p.m., Dr. Lawrence Hookey to present “A Randomized, Assessor-Blinded, Multicenter Study Demonstrates the Efficacy and Safety of a New Ready-to-Drink Low Volume Bowel Preparation Prior to Colonoscopy” (Poster # Tu2010)

June 5, 2018
·
6 min read
Drug Development

Landos Biopharma Announces Human Translational Results for Mechanisms of BT-11 in IBD at Digestive Disease Week 2018

Landos Biopharma, Inc. presented findings from mechanisms of action studies for its lead candidate, BT-11 in models of Crohn’s disease (CD) and Ulcerative Colitis (UC) at Digestive Disease Week 2018.

June 5, 2018
·
5 min read
Pharm Country

Synergy Pharmaceuticals Highlights New Data at Digestive Disease Week (DDW) 2018 Linking Uroguanylin Deficiency to Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome with Constipation (IBS-C)

Synergy Pharmaceuticals Inc. announced new data presented at Digestive Disease Week (DDW) 2018 showing chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) are associated with depressed levels of uroguanylin, a naturally occurring and endogenous human GI peptide.

June 5, 2018
·
9 min read
BioForest

New subcutaneous formulation of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) shows positive results for the treatment of active Crohn’s disease in data presented at Digestive Disease Week® 2018

Celltrion Healthcare presented new research at Digestive Disease Week® (DDW) 2018, that shows the efficacy and safety of the CT-P13 subcutaneous (SC) formulation is comparable to the CT-P13 intravenous (IV) formulation up to week 30 in patients with active Crohn’s disease (CD).

June 5, 2018
·
5 min read
Pharm Country

Capital Blue Health and Wellness Centers Launch Innovative Health Coaching Program

Personally tailored coaching allows people to meet health goals at their own pace

June 5, 2018
·
2 min read
Business

Spok Joins Zebra PartnerConnect Channel Program

Spok, Inc. announced its participation in Zebra Technologies’ PartnerConnect channel partner program.

June 5, 2018
·
2 min read
Drug Development

Synergy Pharmaceuticals to Present New Analysis of Therapeutic Risk and Benefit of TRULANCE® (plecanatide) and Linaclotide in Chronic Idiopathic Constipation (CIC) Patients at Digestive Disease Week (DDW)

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that the company will present a new risk/benefit analysis from pooled Phase 3 study data evaluating TRULANCE® (plecanatide) and linaclotide for the treatment of adults with chronic idiopathic constipation (CIC).

June 5, 2018
·
8 min read
Business

Tenet Diagnostics Appoints Sean Farrell, VP Sales & Strategy: Experienced Strategist, Team Builder for Laboratory and Addiction Treatment to Expand National Footprint

Tenet Diagnostics announces the appointment of Sean Farrell as vice president, Sales and Strategy.

June 5, 2018
·
2 min read
Biotech Beach

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds HempBone Bacon Apple Donuts to CBD Pet Product Line

Medical Marijuana, Inc. announced its newest cannabidiol (CBD) pet product, Phyto Animal Health HempBone Bacon Apple Donuts.

June 5, 2018
·
4 min read